Market Trends Leerink upgrades this downbeat biotech, says investors should buy the dipBy admin8996erT0allFebruary 5, 2025 The sell-off in Regeneron Pharmaceuticals presents an opportunity for investors to buy the stock on the cheap, according to Leerink…
